SG Americas Securities’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-23,756
| Closed | -$48K | – | 3682 |
|
|
2022
Q1 | $48K | Sell |
23,756
-11,653
| -33% | -$22.9K | ﹤0.01% | 2839 |
|
|
2021
Q4 | $96K | Sell |
35,409
-35,941
| -50% | -$133K | ﹤0.01% | 3097 |
|
|
2021
Q3 | $318K | Buy |
71,350
+52,271
| +274% | +$252K | ﹤0.01% | 2888 |
|
|
2021
Q2 | $111K | Sell |
19,079
-61,450
| -76% | -$360K | ﹤0.01% | 2611 |
|
|
2021
Q1 | $565K | Buy |
80,529
+40,184
| +100% | +$269K | ﹤0.01% | 1938 |
|
|
2020
Q4 | $194K | Sell |
40,345
-108,831
| -73% | -$550K | ﹤0.01% | 2647 |
|
|
2020
Q3 | $870K | Sell |
149,176
-53,016
| -26% | -$317K | 0.01% | 1270 |
|
|
2020
Q2 | $1.36M | Sell |
202,192
-397,222
| -66% | -$3.01M | 0.01% | 1115 |
|
|
2020
Q1 | $3.81M | Buy |
+599,414
| New | +$4.81M | 0.04% | 486 |
|
|
2019
Q4 | – | Sell |
-47,027
| Closed | -$185K | – | 3496 |
|
|
2019
Q3 | $185K | Sell |
47,027
-42,526
| -47% | -$344K | ﹤0.01% | 2395 |
|
|
2019
Q2 | $1.33M | Sell |
89,553
-7,595
| -8% | -$137K | 0.01% | 1256 |
|
|
2019
Q1 | $2.41M | Buy |
97,148
+51,947
| +115% | +$1.3M | 0.02% | 748 |
|
|
2018
Q4 | $812K | Buy |
+45,201
| New | +$924K | 0.01% | 1510 |
|
|
2018
Q3 | – | Sell |
-2,705
| Closed | -$123K | – | 3545 |
|
|
2018
Q2 | $123K | Sell |
2,705
-10,269
| -79% | -$499K | ﹤0.01% | 2946 |
|
|
2018
Q1 | $685K | Buy |
12,974
+6,499
| +100% | +$379K | 0.01% | 1653 |
|
|
2017
Q4 | $440K | Buy |
6,475
+1,010
| +18% | +$70.6K | ﹤0.01% | 1934 |
|
|
2017
Q3 | $450K | Sell |
5,465
-13,848
| -72% | -$1.1M | ﹤0.01% | 1927 |
|
|
2017
Q2 | $1.81M | Buy |
19,313
+14,520
| +303% | +$888K | 0.02% | 963 |
|
|
2017
Q1 | $305K | Sell |
4,793
-22,422
| -82% | -$1.36M | ﹤0.01% | 2166 |
|
|
2016
Q4 | $1.21M | Buy |
+27,215
| New | +$958K | 0.01% | 1192 |
|
|
2016
Q2 | – | Sell |
-6,719
| Closed | -$129K | – | 3094 |
|
|
2016
Q1 | $129K | Buy |
+6,719
| New | +$142K | ﹤0.01% | 2471 |
|
|
2015
Q4 | – | Sell |
-6,981
| Closed | -$642K | – | 3059 |
|
|
2015
Q3 | $642K | Buy |
6,981
+3,542
| +103% | +$307K | ﹤0.01% | 991 |
|
|
2015
Q2 | $302K | Sell |
3,439
-5,620
| -62% | -$481K | ﹤0.01% | 1769 |
|
|
2015
Q1 | $672K | Buy |
9,059
+4,624
| +104% | +$327K | ﹤0.01% | 1317 |
|
|
2014
Q4 | $248K | Buy |
4,435
+1,923
| +77% | +$101K | ﹤0.01% | 2245 |
|
|
2014
Q3 | $114K | Sell |
2,512
-2,886
| -53% | -$121K | ﹤0.01% | 2307 |
|
|
2014
Q2 | $224K | Buy |
+5,398
| New | +$278K | ﹤0.01% | 1985 |
|
|
2013
Q4 | – | Sell |
-2,873
| Closed | -$175K | – | 3111 |
|
|
2013
Q3 | $175K | Buy |
+2,873
| New | +$204K | ﹤0.01% | 2271 |
|
Other funds holding CLVS
PAI
QF
E
PA
SG Americas Securities's CLVS Position: Q2 2022 in Review
SG Americas Securities sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 23,756 shares — an estimated $48K sold.
SG Americas Securities first reported a position in CLVS in Q3 2013 and held it in 28 quarters. The position peaked at $3.81M in Q1 2020. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.
- SG Americas Securities reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
- SG Americas Securities sold 23,756 Clovis Oncology, Inc. shares in Q2 2022, an estimated $48K.
- SG Americas Securities first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 28 quarters.
- SG Americas Securities's Clovis Oncology, Inc. position peaked at $3.81M in Q1 2020.
- 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.
Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.